Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationMaría E. Figueroa, Ari Melnick, Wei Liu et al.|Cancer Cell|2010Cited by 2.7k
Dissecting the treatment-naive ecosystem of human melanoma brain metastasisJana Biermann, Peter Canoll, Johannes C. Melms et al.|Cell|2022Cited by 216
Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patchKristjan H. Gretarsson, Chao Lü|Science Advances|2024Cited by 22
Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumorsDimitris Karagiannis, Chao Lü|Cell Reports|2023Cited by 20